Predominance of hospital-associated MRSA among cystic fibrosis patients in a Turkish reference cystic fibrosis centre

Journal of Chemotherapy

Volumn 24, Issue 4, 2012, Pages 195-200

  Yurdakul, Pinar ^a   Ocal, Hamdiye Yesim ^a   Gulmez, Dolunay ^a   Yalcin, Ebru ^a   Dogru, Deniz ^a   Cinel, Guzin ^a   Özcelik, Uǧur ^a   Kiper, Nural ^a   Sener, Burcin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cystic fibrosis; MRSA; PVL; SCCmec

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC);

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; TURKEY;

EID: 84866243300     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947812Y.0000000024     Document Type: Article

References (33)

1. Stone A, Saiman L. Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis. Curr Opin Pulm Med. 2007;13(6):515-21.
2. Goss CH, Muhlebach MS. Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros. 2011;10(5):298-306.
3. Cafiso V, Bertuccio T, Spina D, Campanile F, Bongiorno D, Santagati M, et al. Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 2010;29(10):1277-85.
4. Reiter KC, Machado AB, Freitas AL, Barth AL. High prevalence of methicillin-resistant Staphylococcus aureus with SCCmec type III in cystic fibrosis patients in southern, Brazil. Rev Soc Bras Med Trop. 2010;43(4):377-81.
5. Goodrich JS, Sutton-Shields TN, Kerr A, Wedd JP, Miller MB, Gilligan PH. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol. 2009;47(4):1231-3.
6. Glikman D, Siegel JD, David MZ, Okoro NM, Boyle-Vavra S, Dowell ML, et al. Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic communityassociated methicillin-resistant S. aureus. Chest. 2008; 133(6):1381-7.
7. Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM, Jr, Buller RS, et al. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. 2007;131(6):1718-25.
8. Cystic Fibrosis Foundation. Patient registry: Annual data report 2008. Bethesda (MD): Cystic Fibrosis Foundation; 2009.
9. De Vrankrijker AM, Wolfs TF, van der Ent CK. Challenging and emerging pathogens in cystic fibrosis. Paediatr Respir Rev. 2010;11(4):246-54.
10. Sesli Cetin E, Us E, Gunes H, Kaya S, Tekeli A, Demirci M. Investigation of Panton-Valentine leukocidin expressing Staphylococcus aureus colonization among children in a child care center. Am J Infect Contr. 2010;38(7):565-7.
11. Akoglu H, Zarakolu P, Altun B, Unal S. Epidemiological and molecular characteristics of hospital-acquired methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe Universty Adult Hospital in 2004-2005. Mikrobiyol Bul. 2010;44(3):343-355. Turkish.
12. Kilic A, Guclu AU, Senses Z, Bedir O, Aydogan H, Basustaoglu AC. Staphylococcal cassette chromosome mec (SCCmec) characterization and panton-valentine leukocidin gene occurrence for methicillin-resistant Staphylococcus aureus in Turkey, from 2003 to 2006. Antonie Van Leeuwenhoek. 2008;94(4):607-14.
13. Clinical laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. 2010; 18th Informational Supplement (M100-S20).
14. Unal S, Hoskins J, Flokowitsch JE, Wu CY, Preston DA, Skatrud PL. Detection of methicillin-resistant staphylococci by using the polymerase chain reaction. J Clin Microbiol. 1992;30(7):1685-91.
15. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46(7):2155-61.
16. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29(5):1128-32.
17. Kahl BC. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease. IJMM. 2010;300(8):514-9.
18. Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, et al. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007;42(6):513-8.
19. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest. 2009;136(6):1554-60.
20. Dogan OSB, Yalcin E, Dogru D, Ozcelik U, Kiper N. MRSA and macrolide resistant Staphylococcus aureus colonization rates in a Turkish CF center. Proceeding of the 32nd European Cystic Fibrosis Conference; 2009 Jun 10-13; Brest, France.
21. Steinkamp G, Wiedemann B, Rietschel E, Krahl A, Gielen J, Barmeier H, et al. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros. 2005;4(1):41-8.
22. Spicuzza L, Sciuto C, Vitaliti G, Di Dio G, Leonardi S, La Rosa M. Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur J Clin Microbiol Infect Dis. 2009;28(2):191-5.
23. Molina A, Del Campo R, Maiz L, Morosini MI, Lamas A, Baquero F, et al. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother. 2008;62(5):961-7.
24. Motoshima M, Yanagihara K, Morinaga Y, Matsuda J, Sugahara K, Yamada Y, et al. Genetic diagnosis of community-acquired RSA: a multiplex real-time PCR method for Staphylococcal cassette chromosome mec typing and detecting toxin genes. Tohoku J Exp Med. 2010;220(2):165-70.
25. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother. 2009;53(12):4961-7.
26. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753-9.
27. Campana S, Cocchi P, Doring G, Taccetti G, Moroney SM. Emergence of an epidemic clone of community-associated methicillin-resistant panton-valentine leucocidin-negative Staphylococcus aureus in cystic fibrosis patient populations. J Clin Microbiol. 2007;45(9):3146; author reply 3146-7.
28. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract ethicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010;303(23):2386-92.
29. Gulmez D SB, Ercis S, Karakaya J, Hasçelik G. The presence of Panton-Valentine Leukocidin and the distribution of clinical Staphylococcus aureus isolates in a Turkish University Hospital. American Society for Microbiology 109th General Meeting; 2009 May 17-21; Philadelphia, PA, USA.
30. Doe SJ, Mcsorley A, Isalska B, Kearns AM, Bright-Thomas R, Brennan AL, et al. Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres. J Cyst Fibros. 2010;9(2):104-9.
31. Karahan ZC, Dolapci I, Tekeli A. Influence of reaction optimization on the results of PCR amplification of Panton-Valentine leukocidin genes among Staphylococcus aureus isolates. Mikrobiyol Bul. 2009;43 (4):519-28. Turkish.
32. Kirdar S, Arslan U, Tuncer I, Findik D, Bozdogan B. Investigation of the clonality and Panton-Valentine leukocidin toxin among nosocomial methicillin-resistant Staphylococcus aureus strains. Mikrobiyol Bul. 2009;43 (4):529-33. Turkish.
33. Branger C, Gardye C, Galdbart JO, Deschamps C, Lambert N. Genetic relationship between methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains from France and from international sources: delineation of genomic groups. J Clin Microbiol. 2003;41(7):2946-51.